Use access key #2 to skip to page content.
$2.41 0.02 (0.84%)
7/3/2008 1:00 PM

Cell Genesys, Inc. (CEGE)

CAPS Rating:
***

A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.

View All Commentary (CEGE)

Recs

0

Avatar Marauder03 (< 20) Submitted: 4/25/08 11:51 AM : Outperform Start Price: $3.87 CEGE Score: -28.91

Prostate cance is #1 cancer in men, for now...

Report this Post Replies: 0 | Reply

Featured Broker Partners